These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23189222)

  • 1. Losartan to prevent hyperenzymemia after endoscopic retrograde cholangiopan-creatography: A randomized clinical trial.
    Bexelius TS; Blomberg J; Lu YX; Håkansson HO; Möller P; Nordgren CE; Arnelo U; Lagergren J; Lindblad M
    World J Gastrointest Endosc; 2012 Nov; 4(11):506-12. PubMed ID: 23189222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial.
    Tsujino T; Komatsu Y; Isayama H; Hirano K; Sasahira N; Yamamoto N; Toda N; Ito Y; Nakai Y; Tada M; Matsumura M; Yoshida H; Kawabe T; Shiratori Y; Omata M
    Clin Gastroenterol Hepatol; 2005 Apr; 3(4):376-83. PubMed ID: 15822043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone-2: a multicenter, randomized, placebo-controlled, double-blind clinical trial.
    Uchino R; Isayama H; Tsujino T; Sasahira N; Ito Y; Matsubara S; Takahara N; Arizumi T; Toda N; Mohri D; Togawa O; Yagioka H; Yanagihara Y; Nakajima K; Akiyama D; Hamada T; Miyabayashi K; Mizuno S; Kawakubo K; Kogure H; Sasaki T; Yamamoto N; Nakai Y; Hirano K; Tada M; Koike K
    Gastrointest Endosc; 2013 Dec; 78(6):842-850. PubMed ID: 23910063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective, randomized, double-blind, placebo-controlled trial of ulinastatin for prevention of hyperenzymemia after double balloon endoscopy via the antegrade approach.
    Itaba S; Nakamura K; Aso A; Tokunaga S; Akiho H; Ihara E; Iboshi Y; Iwasa T; Akahoshi K; Ito T; Takayanagi R
    Dig Endosc; 2013 Jul; 25(4):421-7. PubMed ID: 23368820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
    Kawaguchi Y; Ogawa M; Omata F; Ito H; Shimosegawa T; Mine T
    World J Gastroenterol; 2012 Apr; 18(14):1635-41. PubMed ID: 22529693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial.
    Ito K; Fujita N; Noda Y; Kobayashi G; Obana T; Horaguchi J; Takasawa O; Koshita S; Kanno Y; Ogawa T
    J Gastroenterol; 2010 Nov; 45(11):1183-91. PubMed ID: 20607310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.
    Devière J; Le Moine O; Van Laethem JL; Eisendrath P; Ghilain A; Severs N; Cohard M
    Gastroenterology; 2001 Feb; 120(2):498-505. PubMed ID: 11159890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of changing our cannulation method on the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis after pancreatic guidewire placement.
    Hisa T; Matsumoto R; Takamatsu M; Furutake M
    World J Gastroenterol; 2011 Dec; 17(48):5289-94. PubMed ID: 22219598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis.
    Rabenstein T; Fischer B; Wiessner V; Schmidt H; Radespiel-Tröger M; Hochberger J; Mühldorfer S; Nusko G; Messmann H; Schölmerich J; Schulz HJ; Schönekäs H; Hahn EG; Schneider HT
    Gastrointest Endosc; 2004 May; 59(6):606-13. PubMed ID: 15114301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial.
    Tsujino T; Isayama H; Nakai Y; Ito Y; Togawa O; Toda N; Arizumi T; Kogure H; Yamamoto K; Mizuno S; Yashima Y; Yagioka H; Sasaki T; Matsubara S; Yamamoto N; Hirano K; Sasahira N; Tada M; Koike K
    J Gastroenterol; 2013 Aug; 48(8):982-8. PubMed ID: 23090004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Ishiwatari H; Urata T; Yasuda I; Matsusaki S; Hisai H; Kawakami H; Ono M; Iwashita T; Doi S; Kawakubo K; Hayashi T; Sonoda T; Sakamoto N; Kato J
    Dig Dis Sci; 2016 Nov; 61(11):3292-3301. PubMed ID: 27447477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.
    Andriulli A; Solmi L; Loperfido S; Leo P; Festa V; Belmonte A; Spirito F; Silla M; Forte G; Terruzzi V; Marenco G; Ciliberto E; Sabatino A; Monica F; Magnolia MR; Perri F
    Clin Gastroenterol Hepatol; 2004 Aug; 2(8):713-8. PubMed ID: 15290665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis.
    Sudhindran S; Bromwich E; Edwards PR
    Br J Surg; 2001 Sep; 88(9):1178-82. PubMed ID: 11531863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic guidewire placement for achieving selective biliary cannulation during endoscopic retrograde cholangio-pancreatography.
    Ito K; Fujita N; Noda Y; Kobayashi G; Obana T; Horaguchi J; Takasawa O; Koshita S; Kanno Y
    World J Gastroenterol; 2008 Sep; 14(36):5595-600; discussion 5599. PubMed ID: 18810780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Precut Sphincterotomy Does Not Increase Risk During Endoscopic Retrograde Cholangiopancreatography in Patients With Difficult Biliary Access: A Meta-analysis of Randomized Controlled Trials.
    Sundaralingam P; Masson P; Bourke MJ
    Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1722-1729.e2. PubMed ID: 26144018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study.
    Sherman S; Blaut U; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Earle D; Temkit M; Lehman GA
    Gastrointest Endosc; 2003 Jul; 58(1):23-9. PubMed ID: 12838216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wire-guided biliary cannulation technique does not reduce the risk of post-ERCP pancreatitis: multicenter randomized controlled trial.
    Kobayashi G; Fujita N; Imaizumi K; Irisawa A; Suzuki M; Murakami A; Oana S; Makino N; Komatsuda T; Yoneyama K
    Dig Endosc; 2013 May; 25(3):295-302. PubMed ID: 23368891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography.
    Sand J; Nordback I
    Digestion; 1993; 54(2):105-11. PubMed ID: 8319838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
    Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA
    Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.